Back to results
US 2022/0017490 A1Published application
Co-crystals of 2-methyl-1 -[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl) pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol, compositions and methods of use thereof
AssigneeCelgene Corporation
InventorsEric A. Fromme, Kevin J. Klopfer
Life of this patent
Estimating the term…
Abstract
Provided herein are co-crystals comprising Compound 1 and a coformer. Pharmaceutical compositions comprising the co-crystals and methods for treating, preventing and managing disease are also disclosed.
Claims37
A co-crystal comprising 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol and a coformer selected from a group consisting of fumaric acid, succinic acid, benzoic acid, citric acid, nicotinamide, lactamide, 4-hydroxybenzamide, uracil, and saccharin.
37-49. (canceled)
Dependencies are inferred from the claim text.